Dutch mobile health startup SkinVision has revealed its new algorithm that can detect most common forms of deadly skin cancer. Previously focused on detecting melanoma skin cancer, the app can now identify Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC) too, the first app ever to do that.
Across the world, more than one billion people are at risk of developing skin cancer at some point in their lives. Helping them prepare is a selected group of dermatologists. For example 10,000 in the US and only 550 in the UK. SkinVision’s new algorithm will help provide people with a means to assess moles for risk indication on demand to save time and lives. Users can download the app for free and can perform a number of free assessments as well.
There is a seamless connection between users and their doctors to monitor skin lesions with a personal archive that can be used as reference during visits, saving time and improving efficiency for dermatologists.
“Our mission is to empower people to early detect skin cancer, which is highly important for possible treatment options,” says SkinVision founder and CEO Erik de Heus. “We aim to save 250,000 lives in the next decade.”
Melanoma is a type of skin cancer that forms in the cells responsible for skin pigmentation, known as melanocytes. Although it is less common than other forms of skin cancer, it is much more aggressive. In the United States alone, melanoma accounts for more than, 10,000 of the 13,000 deaths caused by skin cancer each year. Research shows that 5,4 million non-melanoma skin cancer cases are identified every year in the US.
Do you have an innovative project with a focus on technology transfer between HEALTH and ICT, AeroSpace, Agri-Food sectors?